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ABTRACT 
 
Introduction: 
The metabolic syndrome is reaching epidemic proportions worldwide. Sleep duration has been 
shown to be important in glucose homeostasis. It has been reported that the specific stages of 
sleep (most importantly slow wave sleep and rapid eye movement sleep) each play their part in 
glucose homeostasis. The aim of this thesis was to determine if partial sleep deprivation has an 
impact on insulin sensitivity. Specifically, we sought to determine if 3 nights of 5h sleep 
opportunity when compared to 3 nights of 9h sleep opportunity with food being ad libitum, would 
result in decreased insulin sensitivity.   
 
Methods: 
13 healthy subjects (7 men, 6 women) aged 24.77 ± 4.02 (Mean ± SD), participated in the study. 
Subjects were admitted to the Clinical Translational Research Center (CTRC) at the University of 
Colorado Health Sciences Center for the duration of the study. Subjects lived in a hospital room 
for 14-15 days, depending on which sleep deprivation protocol they were randomized to. Total 
sleep time (TST) and sleep efficiency (SE) were assessed via actigraphy daily. Plasma glucose 
and insulin levels were obtained from oral glucose tolerance tests (OGTTs), assessed in the 
morning following a 9h baseline night, 3 days of 9h sleep per night, and 3 days of 5h sleep per 
night. Insulin sensitivity was assessed using the Matsuda index and HOMA-IR. Mixed model 
ANOVA with subject as a random factor and day, time and/or condition as fixed factors was used 
to analyze data.  
 
Results: 
Main effects of day (p<0.000001) and of subject (p<0.000001) were seen for TST. Planned 
comparisons showed significantly less TST for each day of the 5h sleep opportunity condition, as 
compared to baseline and each respective 9h day sleep opportunity. Main effects of day (p<0.001) 
and of subject (p<0.000001) were also seen for SE. Planned comparisons showed significantly 
higher SE for each day of the 5h sleep opportunity condition versus the 9h day sleep opportunity. 
Significant effects were seen for subject (p<0.00085), time (p<0.00), and significant condition × 
subject (0.012173) and time × subject (p<0.00) interactions for glucose levels. Significant effects 
were seen for condition (p<0.015392), time (p<0.00), and significant condition × subject 
(p<0.050201) and time × subject (p<0.000001) interactions for insulin levels. Significant main 
effects were also seen for condition (p<0.05) and for subject (p<0.05) for the Matsuda index. 
Planned comparisons revealed a significant reduction in the Matsuda index for the 5h condition 
versus baseline (p=0.01). Planned comparisons showed a significant increase in HOMA-IR for 
the 5h condition vs. baseline (p<0.05). 
 
Discussion: 
A sleep opportunity of 5h for 3 nights resulted in a reduction in insulin sensitivity when compared 
to a baseline 9h sleep opportunity. An increase in insulin levels following the sleep restriction 
condition was associated with normal glucose levels. These results indicate a reduction in insulin 
sensitivity following sleep restriction of 5h. The study’s results on insulin sensitivity are similar 
to those seen in obese and aging individuals and provide important implications into the effects of 
sleep restriction on metabolic health. 
 
Support: 
NIH/NHLBI R01 HL085705, with the support of UCB and UCH CTRC: physicians, nurses, 
dieticians, biostasticians, research advocates, informatics core staff, administrative staff, and 
Chronobiology Laboratory research equipment. 
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Introduction:  
A voluntary reduction in sleep duration has become a worldwide practice to meet 
the demands of modern society [13, 21].  Findings from several studies have shown that 
sleep duration and quality are important in the modulation of glucose metabolism [35, 36, 
8, 17, 23, 29].  Additionally, findings from epidemiological studies have indicated that 
chronic sleep restriction is correlated with an increased risk of type 2 diabetes [26].  
Findings from research studies have shown that not only does chronic sleep curtailment 
have an effect on glucose metabolism, but acute sleep deprivation (i.e. one night) can 
alter glucose tolerance and insulin sensitivity [37, 8, 30].  In addition to these notable 
effects, the different stages of sleep, most importantly slow-wave sleep (SWS) [32] and 
rapid eye movement sleep (REM) [28], are known to play a role in glucose homeostasis 
during a sleep episode.  SWS has been shown to be better preserved than that of REM 
sleep during a sleep restriction of 4h [30].  Glucose tolerance has been shown to be 
modulated by sleep, as well as the circadian system, driven by the superchiasmatic 
nucleus (SCN) (regulator of circadian rhythms [10]) in the hypothalamus [36].  It has 
been reported that a SCN-lesion disrupts glucose homeostasis and results in the lack of 
rise in cortisol and glucose levels shortly after awakening (morning arousal) [15].  Due to 
the circadian influence, several studies have utilized constant glucose infusion, 
continuous enteral nutrition or an identical meal and interval protocol to determine how 
the circadian system affects glucose tolerance throughout the day and night, as well as the 
impact of sleep on glucose tolerance [35, 12, 28].   
Insulin sensitivity refers to the ability of insulin to inhibit hepatic glucose 
production and promote glucose disposal by peripheral tissues [29].  It is commonly 
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assessed from procedures, such as oral glucose tolerance tests, intravenous glucose 
tolerance tests, fasting measures, and the hyper-insulinemic-euglycemic clamp 
(considered the gold standard for the measurement of insulin sensitivity [8]).  The hyper-
insulinemic-euglycemic clamp involves the infusion of insulin at a set (clamped) level 
and glucose is infused, as needed to maintain euglycemia (normal glucose levels).  A 
sampling catheter is placed in the contralateral (opposite) arm for blood sampling [8].  If 
a smaller than normal amount of glucose needs to be infused to maintain euglycemia, 
then there is an indication of reduced insulin sensitivity.  The Matsuda index and 
homeostatic model of assessment are indices that have been established to determine the 
insulin sensitivity that is assessed from the OGTT and fasting measures, respectively.  
Insulin sensitivity has become an important topic in modern day society, due to the 
increased prevalence of diabetes and sleep restriction.  Sleep restriction has been shown 
to cause a reduction in insulin sensitivity (i.e., more insulin is required to maintain 
glucose homeostasis) [8, 14, 29, 39].  Acute sleep restriction results in increased glucose 
and decreased insulin levels, which is indicative of decreased glucose tolerance [29].  
Chronic sleep restriction has been shown to be associated with insulin 
resistance/impaired insulin sensitivity, putting an individual in a pre-diabetic state [29].  
This may lead to a permanent state of insulin resistance/impaired insulin sensitivity that 
is defined as type 2 diabetes.  To the best of our knowledge, the current study is the first 
study to look at insulin sensitivity, with food being ad libitum, following a protocol that 
simulates sleep restriction across a modern work week, in which an individual might 
encounter in their life.     
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Hypothesis:  The present study was designed to determine if 3 nights of 5h sleep 
opportunity compared to 3 nights of 9h sleep opportunity decreases insulin sensitivity.   
Sleep- Glucose Homeostasis and Metabolism 
Nocturnal Sleep  
 Glucose homeostasis is dependent on both glucose production (from the liver 
during the post-absorptive state and the gut during the post-prandial state) and utilization 
[12, 18, 29].  Findings from studies have shown that sleep is important in the modulation 
and homeostasis of glucose [35, 36, 8, 17, 23, 29].  Specifically, nocturnal sleep provides 
multiple mechanisms that keep glucose levels relatively stable throughout the sleep 
episode, even though this period of time is associated with a fasting state [36, 29].   
According to Van Cauter et al [36], during a nocturnal sleep episode of 8h (0:00-
0:800), plasma glucose levels remain relatively stable throughout the night.  This is very 
different from the daytime (08:00-16:00) results that show a notable decrease in plasma 
glucose when subjects were kept awake.  Furthermore, the rate of production of glucose 
and rate of utilization of glucose shows a U-shaped curve throughout the sleep period.  
These concurrent U-shaped curves show endogenous production of glucose, mainly by 
the liver, is likely associated with glucose utilization by tissues.  Daytime values for rate 
of production and rate of utilization of glucose are relatively stable and do not show the 
same nadir as their respective nighttime values.  The latter implies that overall glucose 
homeostasis is modulated by sleep.   
Sleep Stages and Hormones- Roles in Glucose Homeostasis during Sleep 
 The adult human sleep cycle is composed of two types of sleep: rapid eye 
movement (REM) and non-rapid eye movement (NREM) sleep.  NREM consists of 
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stages 1, 2, and the combined stages 3 and 4, known as slow-wave sleep (SWS) [16].  
Throughout a normal sleep episode (7-9h), the first part of the night an individual spends 
relatively more time in SWS.  During the later part of the night, more time is spent in 
REM sleep.  Findings from research studies have shown that certain sleep stages, most 
importantly SWS and REM, impact glucose metabolism during sleep [27, 29, 32, 30, 33].   
 SWS sleep has been shown to be associated with a decrease in glucose 
effectiveness (clearance of glucose from the body by non-insulin dependent tissues (i.e., 
brain) (SG) [21]), an increase in growth hormone release, inhibition of cortisol secretion, 
decreased sympathetic nervous system activity and increased vagal (parasympathetic) 
tone.  These physiological processes that are impacted by SWS may affect total-body 
glucose homeostasis [32].  Specifically, growth hormone acts to stimulate 
gluconeogenesis in the liver and inhibit peripheral tissue uptake of glucose.  Therefore, 
growth hormone produces anti-insulin like effects on total body glucose metabolism.   
The decrease in glucose utilization that is observed in the early part of the night is 
thought to be mainly due to a reduction in cerebral glucose utilization during SWS [29].  
As opposed to SWS, REM sleep and wakefulness are associated with an increase in 
glucose utilization [28].  The increase in glucose utilization towards the end of the sleep 
episode [36] is consistent with the latter.  As opposed to GH, an increase in cortisol 
secretion occurs during the second half of the sleep episode, a time when REM sleep 
amounts are high [27].  Previously described, glucose tolerance improves during the 
second half of a sleep episode, under constant glucose infusion conditions.  This 
improvement in glucose tolerance may be associated with the increased secretion of 
cortisol, seen in the second half of the sleep episode.  According to these findings, the 
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specific sleep stages, most importantly SWS and REM sleep are thus important in 
glucose homeostasis during a sleep episode. 
24-hour Glucose and Insulin Profiles  
Glucose tolerance is defined as the ability of insulin to clear (or restore) blood 
glucose levels to normal after a glucose challenge [12].  It has been shown that glucose 
tolerance starts to decrease throughout the late afternoon and early evening [35, 36, 12, 
14].  Constant glucose infusion protocols (e.g., continuous enteral nutrition protocol over 
a 24h period or greater, or a 24h study with identical meals at even intervals [35, 12, 28]) 
have been used to better understand factors that contribute to changes in glucose levels 
during nocturnal sleep. Constant glucose infusion inhibits endogenous glucose production 
(EGP); the liver is the main contributor to EGP.  Findings from these studies indicate that 
there is a decrease in glucose utilization by both insulin-dependent (i.e., muscle and 
adipose tissue) and independent (i.e., brain) tissues during the nocturnal sleep episode.  
The observed decrease in glucose utilization may be a result of a reduction in insulin 
sensitivity [35, 12, 28].   
Findings from Van Cauter et al [37] indicate that there is a reduction in glucose 
tolerance throughout the day and into the night time, as assessed by blood glucose and the 
insulin response to 3 identical meals given 6 hours apart from each other (08:00, 14:00, 
20:00).  Although they found an increase in blood glucose levels in response to each 
subsequent meal than the previous meal, the insulin secretion rate (ISR) and insulin levels 
did not compensate in response to the rising glucose levels.  The latter may indicate a 
circadian influence in the set point at which -cells respond to glucose, with a reduction 
in the responsiveness in the evening resulting in increased blood glucose concentrations 
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[37].  Van Cauter et al [35] also demonstrated that ISR and glucose levels show a marked 
increase in response to sleep onset, peak in the middle of a nocturnal sleep episode, and 
decrease in the second half of the sleep episode during a constant infusion of glucose.  
These spikes in both the ISR and glucose levels during the sleep episode are juxtaposed 
to the lower ISR and glucose levels during the daytime, even though the subjects are 
under a constant infusion protocol.  In addition, in response to sleep onset, ISR increased 
as glucose tolerance decreased during sleep, regardless of when sleep was scheduled.  
This specific finding indicates that sleep triggers events that result in impaired glucose 
tolerance.  These findings from studies using a constant infusion and identical meal and 
interval protocol indicate that sleep and circadian rhythms modulate glucose homeostasis. 
 
Sleep Deprivation- Glucose Homeostasis and Metabolism 
According to the Centers for Disease Control, from 2004-2006, 28.5% of men and 
women in the U.S. aged 18 or older, reported getting 6 or less hours of sleep per night 
[25].  Additionally, findings from Morselli et al [21] show that 44% of US adults obtain 
less than 7h of sleep per work night.  Besides the obvious cognitive impairment, sleep 
restriction may contribute to the development of obesity and/or insulin resistance [6, 36, 
8, 12, 14, 17, 23, 38, 39].  According to Figure 1, acute sleep deprivation (i.e., one night 
of total sleep deprivation) results in increased levels of glucose and suppressed levels of 
insulin.  Chronic sleep restriction can increase the levels of insulin, even though glucose 
levels may be normal.  These results are indicative of decreased insulin sensitivity, since 
more insulin is required to clear the same amount of glucose.  When these levels are 
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sustained chronically, it can lead to a pre-diabetic state of impaired glucose tolerance and 
insulin resistance and eventually lead to an increased risk for developing type-2 diabetes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chronic/Total Sleep Deprivation 
 Modern society’s increasing demands, whether it is work or social, have increased 
the prevalence of chronic sleep restriction.  One example is seen with individuals that 
undergo shift work (i.e., doctors, nurses, construction workers, etc.) [3].  According to the 
study by Scheen et al [24], disturbances in glucose regulation can result from chronic 
disturbances in sleep, such as those occurring in shift workers.  Experimental sleep 
Figure 1. A schematic representation of the effects of 
acute and chronic sleep deprivation. Both pathways 
subsequently leading to glucose dysregulation. (Adapted 
from Spiegel et al., 2005 (29)) 
Acute Sleep 
Deprivation 
Chronic Sleep 
Deprivation 
Increased Glucose 
Decreased Insulin 
Decreased 
Glucose 
Tolerance 
Normal Glucose 
Increased Insulin 
Insulin 
Resistance 
Increased Risk for 
Type-2 Diabetes 
Increased Risk 
for Type 2 
Diabetes 
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disruption has been shown to disturb glucose regulation.  For example, if SWS is 
experimentally suppressed by nearly 90%, insulin sensitivity is decreased by 25% and 
reaches a level that is consistent with aging individuals, as well as populations at high 
risk for diabetes [5].         
Sleep Restriction 
 Sleep restriction, as previously noted, has been associated with an increased risk 
for the development of insulin resistance (characterized by needing higher than normal 
amounts of insulin to reduce blood glucose levels, following administration of the same 
amount of exogenous glucose [14]) [8, 14, 39] and impaired glucose tolerance [8, 14, 30, 
39], which in turn may result in the development of type 2 diabetes in the future.  
Specifically, findings from a study by Spiegel et al [30] showed that 4h in bed for 6 
nights when compared to 12h in bed for 6 nights resulted in negative effects on glucose 
metabolism and other endocrine functions.  Following the 4h sleep duration, the subjects 
displayed a reduction in glucose tolerance, acute insulin response to glucose 
(characterized by pancreatic beta-cell responsiveness [21]) and glucose effectiveness.   
Furthermore, Donga et al. [8] found that with only a single night of sleep 
restriction with a sleep opportunity of 4h when compared to a control condition of 8.5h of 
scheduled sleep, subjects displayed a 19-25% reduction in insulin sensitivity in multiple 
pathways.  These pathways consisted of EGP and glucose uptake, as well as peripheral 
lipolysis, indicated by the increased non-esterified fatty acid (NEFA) levels, due to the 
reduction of insulin’s action on adipose tissue.  Sleep restriction results in alterations in 
the relative proportion of the specific sleep stages.  The study by Spiegel et al [30] 
indicated that the proportion of SWS increased when the subjects were only allowed 4h 
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in bed per night for 6 nights as opposed to 12h in bed per night for 6 nights.  This 
increase in the proportion of SWS may be a compensatory mechanism to maintain stable 
glucose levels.  
 
Measurement of Glucose Homeostasis and Insulin Sensitivity 
Oral Glucose Tolerance Test (OGTT)  
The OGTT is the most commonly used method to evaluate whole body glucose 
tolerance and provides a clinically relevant, easily translated, metabolic assessment that 
gives insight into the entire axis under a more physiological setting than does the 
Intravenous Glucose Tolerance Test (IVGTT).  Since, the glucose in an OGTT is given to 
the subject through ingestion, rather than intravenously, it interacts with the 
gastrointestinal system and hence, is more translatable to a real life situation.  The 
justification for using an OGTT rather than an IVGTT is that although OGTTs are less 
precise, IVGTTs are time-consuming and expensive, while OGTTs are much simpler to 
perform [34].  The OGTT is commonly performed following an over-night fast of 12h 
[7]. 
Homeostatic Model of Assessment of Insulin Resistance (HOMA-IR) 
The homeostatic model of assessment of insulin resistance (HOMA-IR) was used 
in this thesis to measure whole-body insulin sensitivity.  HOMA was first established by 
Matthews et al [19] in 1985.  According to the formula, the higher the HOMA, the worse 
insulin sensitivity the subject displays.  Matthews et al [19] used HOMA to assess insulin 
resistance and the deficiency of -cell function.  Spiegel et al [31] assessed insulin 
sensitivity via HOMA, following a sleep restriction of 4h.  It was reported that post-
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breakfast, HOMA was significantly elevated in the sleep restriction when compared to 
the fully rested state of 12h. 
The Matsuda Index 
The Matsuda index is used as a measure of whole-body insulin sensitivity.  
Matsuda & DeFronzo in 1999 [18], concluded that the Matsuda index is a novel estimate 
of insulin sensitivity that is simple to calculate and provides a reasonable approximation 
of whole-body insulin sensitivity from an OGTT.  Even though HOMA-IR was also used 
to determine whole-body insulin sensitivity, the equation assumes that the hepatic and 
peripheral insulin sensitivities are equivalent within an individual [18].  Given this 
information, the HOMA (primarily liver) and the Matsuda index (liver and muscle) 
provide different information [18].  Although the Matsuda index serves as a measure of 
whole-body insulin sensitivity, other indices have been developed to measure specific 
tissue insulin sensitivity, such as skeletal muscle insulin sensitivity (SMIS) and hepatic 
(liver) insulin sensitivity (HIS) [1].  
The current study was designed to determine if short sleep duration would result 
in a reduction in insulin sensitivity.  Specifically, we hypothesized that 3 nights of 5h 
sleep opportunity when compared to 3 nights of 9h sleep opportunity, will result in a 
reduction in insulin sensitivity, as assessed by an oral glucose tolerance test and analyzed 
via the Matsuda index and HOMA-IR.  
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Methods 
 
Subjects: 
 13 healthy subjects (7 men, 6 women) aged 24.77 ± 4.02 (Mean ± SD), 
participated in the study.  Subjects were recruited via flyers, online advertisements (i.e. 
Buff Bulletin and Craigslist), and online surveys (i.e. RED Cap).  Exclusion criteria 
consisted of any history of acute/chronic medical or psychiatric disorder, use of 
prescription medication (other than hormonal contraceptives), BMI outside the range of 
18.5 to 24.9, shift work within 6 months of the health screening visit, less than 3 months 
living at Denver altitude, traveling more than one time zone during the one month prior to 
the study, and conditions related to sleep disorders, as determined from medical history, 
sleep history, physical examination, or polysomnogram (first night of study).   
Subjects gave written informed consent and the protocol was approved by the 
Colorado Multiple Institutional Review Board (COMIRB).  Subjects were deemed 
physically healthy after passing a thorough screening visit at the Clinical Translational 
Research Center on the CU Boulder campus.  The screening tests included: medical 
history, physical examination, blood chemistries, 12-lead EKG, DEXA scan and urine 
toxicology. 
Prior to the start of the study, subjects were asked to keep a consistent self-
selected sleep schedule of ~9h for 7 days at home, verified by actigraphy (Actiwatch-L 
Mini Mitter, Bend, OR), sleep logs and call-ins to a time stamped recorder.  Medications, 
caffeine, alcohol, and nicotine were proscribed 3 days prior to testing.  3 days prior to the 
start of the study, subjects were asked to consume an outpatient diet provided by the 
CTRC nutritionists.  The energy content of the diet was designed to meet individual daily 
energy requirements (RMR × an activity factor). 
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Protocol: 
Subjects participated in one of two cross over designs (Figures 2 & 3).  Subjects 
experienced both sleep loss and adequate sleep conditions with equal numbers exposed to 
sleep loss and adequate sleep first.  The following protocol outlines assessments relative 
to the current thesis that is part of a larger study and does not include the full protocol. 
 
Baseline Assessments: Days 1-3 (Figures 2 & 3)  
The study began with admission to the CTRC on day 1 (Figures 2 & 3).  The three 
inpatient days of segment A were required to assess baseline measurements for the 
outcome variables (sleep and insulin sensitivity).  Subjects were scheduled to sleep (black 
bars) and wake (gray bars) at their regularly scheduled times for 3 days.  Time of day is 
plotted as relative time with scheduled wake time arbitrarily assigned a value of 0800h 
and all other times were referenced to this value.  The actual clock hour was determined 
by the subject’s habitual schedule the week prior to entry into the laboratory. Light 
exposure in the laboratory was a combination of natural sunlight and artificial room 
lighting during scheduled wakefulness and darkness during scheduled sleep.  Food intake 
for the first three days was the same energy balance diet as the outpatient diet.  Wrist 
actigraphy was continuously measured to assess sleep and wakefulness.  On day 2, 
baseline assessments for fasting glucose levels and oral glucose tolerance testing were 
performed (indicated by an OGTT in Figures 2 & 3).   
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Relative Clock Hour 
    0800                                  1600                   2400                                                                 0800 
1         Baseline      
          
2            OGTT        Baseline       
          
3            Baseline     
          
4             5h    
          
5             5h    
          
6             5h    
          
7            OGTT         5h    
          
8             5h    
          
9           9h    
          
10           9h    
          
11           9h    
          
12            OGTT       9h    
          
13           9h    
          
14            
 
   Figure 2--14 Day Design 
Sleep Restriction (5h per night) followed by adequate sleep(9h per 
night) 
OGTT = Oral Glucose Tolerance Test 
 
Experimental Manipulation, Chronic Sleep Loss and Adequate Sleep Crossover: Days 4-
14/15 (Figures 2 & 3)  
 Subjects were scheduled to sleep (black bars) for 5h per night for 5 nights (nights 4-
8 or nights 9-13, Figures 2 & 3).  Meals were provided ad libitum except the mornings of 
the OGTT where fasting was imposed.  Overnight fasting glucose levels were assessed 
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and oral glucose tolerance testing was performed prior to breakfast on days 7 and 12 of 
the study.  A recovery sleep opportunity was provided ad libitum prior to discharge for 
the group that was scheduled to sleep restriction second (Figure 3).  
 
Relative Clock Hour 
0800                                      1600                     2400                                                                  0800                 
1         Baseline    
          
2            OGTT       Baseline     
          
3            Baseline    
          
4           9h    
          
5           9h    
          
6           9h    
          
7            OGTT       9h    
          
8           9h    
          
9             5h    
          
10             5h    
          
11             5h    
          
12            OGTT         5h   
          
13             5h    
          
14      Ad Lib           
          
15           
 
              Figure 3--15 Day Design 
Adequate Sleep (9h Per Night) followed by sleep restriction (5h per 
night) 
OGTT = Oral Glucose Tolerance Test 
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Materials and Measurements:  
 
Actigraphy 
 
 Subjects were asked to wear an actiwatch (Actiwatch-L Mini Mitter, Bend, OR) 
for the duration of the study.  The actiwatch, which was worn around the wrist of the 
subject, measured light and activity levels.  Actigraphy was used to assess total sleep time 
(TST) and sleep efficiency (SE) throughout the protocol.  Polysomnography (PSG) was 
performed on select nights during the study, but was not analyzed for this thesis.  
Actigraphy has been validated as a reasonable estimate of sleep [2, 20].    
Oral Glucose Tolerance Test 
 
An OGTT was performed on three study days (days 2, 7, and 12) as previously 
indicated in the protocol.  Glucose and insulin were assessed in blood samples (2 ml) 
drawn from an indwelling catheter with heplock at t=-30, -15, 0, 30, 60, 90, 120 minutes 
with 75g glucose ingested at t=0.  2-h post-load glucose levels were assessed to 
determine normal glucose tolerance (< 140 mg/dl (7.8 mmol/l)) impaired glucose 
tolerance (>140 mg-199 mg/dl and > 200 mg/dl as diabetes) [4]. 
Data Analysis:  
 
Actigraphy 
Actigraphy was analyzed with Actiware 3.3 Mini Mitter software.  TST and SE 
were analyzed and calculated using the medium sensitivity setting.  TST was calculated 
from the bed time to wake time and any sleep bouts that occurred during the night.  If for 
example, the subject had to get up to go to the bathroom (as measured as an increase in 
activity levels), such awakenings were taken into account.  SE was calculated as follows: 
    SE% =   Total Sleep Time     
                       Time in Bed 
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Sleep data were compared using the final baseline day (day 3) as the sleep baseline to 
account for adaption to sleeping in the laboratory. 
The Homeostatic Model of Assessment of Insulin Resistance  
 
According to the formula, the higher the HOMA score, the worse the insulin 
sensitivity the subject displays.  Matthews et al [19] used HOMA to investigate the 
comparison of a subject’s fasting glucose and insulin levels with the model to establish 
the contributions of insulin resistance and the deficiency of -cell function to a subject’s 
fasting hyperglycemia.    
The model was calculated as: 
                                            1                                               = HOMA-IR 
        [22.5/(fasting insulin × (fasting glucose/18.01))]     
 
The Matsuda Index 
According to the formula, the higher the Matsuda index, the better the insulin 
sensitivity.  The index takes the fasting plasma glucose (FPG) (glucose sampled at t=0) 
and multiplies it by the fasting plasma insulin (FPI) (insulin sampled at t=0).  FPG and 
FPI refer to an individual’s glucose and insulin levels during a fasted state (i.e., at least 
8h abstaining from eating).  The product of FPG and FPI is then multiplied by the 
product of the mean glucose and insulin concentrations over the course of the OGTT.  
The square root of the result is then divided into 10,000, which serves as a constant to 
obtain numbers ranging from 0-12 [18].   
The index is calculated as:  
   10,000                                 
                                                                          = Matsuda Index 
 
(FPG × FPI) × 
(Mean OGTT glucose concentration ×            
Mean OGTT insulin concentration) 
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Statistics:  
  
Sleep efficiency, total sleep time, Matsuda index, and HOMA-IR were analyzed 
via the Mixed-Model ANOVA approach.  The ANOVA included the following factors: 
Subject was included as a random factor and order (5h or 9h first) time, and condition 
day (Baseline, 5h sleep, 9h sleep) were included as fixed factors.  Planned comparisons 
were computed to compare each condition day to the other.  Two subjects had missing 
data for one of their OGTT tests.  Analyses were assessed with STATISTICA, version 
6.0 (StatSoft Inc).  
Results 
No effects were seen for order of conditions (5h vs. 9h first) for any outcome 
variable, therefore the factor order was removed from all analyses. 
Actigraphy: 
 Mixed-Model analysis revealed significant main effects of condition day 
(F=311.30; p<0.000001) and of subject (F=7.70; p<0.000001) for TST.  Individual 
differences in TST were observed.  Planned comparisons showed significantly less TST 
for each day of the 5h sleep opportunity condition, as compared to baseline and each 
respective 9h day sleep opportunity (day 1 5h vs. day 1 9h) (Figure 4).  No significant 
differences were found between the 9h condition and baseline.  Mixed Model analysis 
also revealed significant main effects of day (F=3.08; p<0.001) and of subject (F=8.85; 
p<0.000001) for SE.  Individual differences in SE were observed.  Planned comparisons 
showed significantly higher SE for each day of the 5h sleep opportunity condition 
compared to the 9h day sleep opportunity (day 1- 5h versus day 1- 9h) (Figure 5).  No 
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significant SE differences were found between the 5h condition or 9h condition days and 
baseline day 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glucose and Insulin Levels during the OGTT: 
Significant effects of subject (F=3.33601; p<0.00085), time (F=34.93969; 
p<0.00), and significant condition × subject (F=1.90798; 0.012173) and time × subject 
(F=4.22417; p<0.00) interactions for glucose levels were observed.  A significant effect 
of condition (F=4.9554; p<0.015392), time (F=40.78414; p<0.00), and significant 
condition × subject (F=1.6226; p<0.050201) and time × subject (F=2.58181; 
p<0.000001) interactions for insulin levels were also found.  As seen in Figure 6, glucose 
70
75
80
85
90
95
100
S
le
e
p
 E
ff
ic
ie
n
c
y
 %
 (
T
S
T
/T
IB
)
9h Sleep
Opportunity
5 days
5h Sleep
Opportunity
5 days
Baseline 9h
Opportunity
3 days
 
Figure 5. Sleep efficiency (SE) profile over 
baseline, sleep restriction (5h sleep opportunity) 
and 9h sleep opportunity.  
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Figure 4. Total Sleep Time (TST) profile 
over baseline, sleep restriction (5h sleep 
opportunity) and 9h sleep opportunity.  
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levels are similar among the three conditions, yet to maintain “normal” glucose levels 
during the 5h sleep restriction OGTT, insulin levels were higher.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Matsuda Index: 
 Significant main effects were seen for condition (F=4.20; p<0.05) and for subject 
(F=5.66; p<0.05) for the Matsuda index.  The significant subject effect indicates inter-
individual variability in Matsuda index scores during the OGTT (Appendix B).  Planned 
comparisons revealed a significant reduction in the Matsuda index for the 5h condition 
versus baseline (Figure 7).  The comparison between the 5h and 9h was not significant 
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Figure 6.  Plasma glucose (left panel) and insulin (right 
panel) levels during the OGTT.  
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(p=0.12).  As seen in (Appendix B), the 5h condition showed worse insulin sensitivity 
compared to baseline and the 9h condition. 
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HOMA-IR: 
No significant effects of condition or subject were observed for HOMA-IR, 
however planned comparisons showed a significant increase in HOMA-IR for the 5h 
sleep condition vs. baseline (p<0.05) (Figure 8). 
 
 
 
Figure 7. Insulin sensitivity was found to be significantly worse 
following the 5h sleep restriction compared to the baseline sleep 
opportunity of 9h (p=0.01).  
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Figure 8. Insulin sensitivity was found to be significantly worse 
following the 5h sleep restriction compared to the baseline sleep 
opportunity of 9h (p<0.05).  
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Discussion   
This study is the first of its kind to provide food ad libitum while looking at 
insulin sensitivity during days of sleep restriction versus days of a 9h adequate sleep 
opportunity.  The study was designed to mimic a traditional work week of inadequate 
sleep.  The comparison between the 5h and 9h sleep conditions revealed that the sleep 
restriction condition resulted in a reduction in insulin sensitivity.  This finding is 
consistent with previous findings of impaired insulin sensitivity following sleep 
restriction of 4h [8, 17].  Donga et al [8] found that in healthy lean adults, following sleep 
restriction of 4h for 1 night, insulin sensitivity (assessed by the hyper-insulinemic-
euglycemic clamp) was decreased from a baseline night of 8.5h.  Following the sleep 
restriction night, glucose infusion rate was significantly decreased (p<0.001) from 
baseline.  Additionally, Spiegel et al [31] found that in healthy adults, sleep restriction of 
4h for 6 nights decreased insulin sensitivity.  Specifically, HOMA was significantly 
higher in the sleep restricted group when compared to the 12h sleep opportunity group 
(1399 ± 153 vs. 1954 ± 188) for the area under the curve (p=0.026), following breakfast 
at 09:00.  
In the current study, glucose levels during the OGTT were similar between sleep 
conditions.  Although glucose levels were similar, higher amounts of insulin were needed 
in the sleep restriction condition to maintain these similar glucose levels.  This finding 
and the results from the Matsuda index and HOMA-IR are indicative of decreased insulin 
sensitivity.  The physiological meaningfulness of the change in insulin sensitivity 
observed in the current study can be considered by comparing the observed changes to 
the effects of aging and obesity on insulin sensitivity.  We found sleep restriction to lower 
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the Matsuda index in healthy young adults from an average of 5.74 to 4.58.  The 4.58 
Matsuda index is similar to that reported average Matsuda index of 5.06 (Men- 4.43; 
Women- 5.32) for subjects as 50-95 years old [22] and that of 4.98 for older (73.74 ± 
11.23) lean individuals [11].  In addition to aging, a study by Gniuli et al [9] found that 
obese individuals display worse insulin sensitivity, assessed by HOMA-IR.  The current 
study’s results for insulin sensitivity show that the 2.52 HOMA-IR for the 5h sleep 
condition fell between two quartiles of overweight subjects (second quartile: BMI 26.71; 
HOMA-IR=1.57, third quartile: BMI 37.94; HOMA-IR=3.82) in the study by Gniuli et al 
[9].   
Strengths: 
   The present study was designed to be well controlled with subjects being in a 
hospital setting.  The study was designed as a counter-balanced, crossover, within-
subjects design, so each subject served as their own control.  Since, subjects were 
provided food ad libitum and the sleep restriction protocol was equated to a modern work 
week, the findings have important implications for the general working population.   
Limitations and Future Research: 
One limitation of the study is that the controlled laboratory conditions do not 
mimic daily life.  Since sleep restriction produces performance impairments similar to 
alcohol intoxication, it is problematic to assess effects of experimentally induced sleep 
restriction under real world conditions to obtain more translatable findings.  Future 
studies could look at this variable of insulin sensitivity under different protocols, such as 
different degrees and durations of sleep restriction.  One could also assess the effects of 
sleep restriction on insulin sensitivity of aging and overweight adults to better understand 
the importance of sleep for overall metabolic health.  
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In conclusion, we have shown that a sleep restriction period of 5h for 5 days 
results in a reduction in insulin sensitivity from baseline.  The current study indicates that 
sleep restriction in healthy young adults impairs insulin sensitivity to a level comparable 
to that found in aging and in obese individuals, indicating that sleep restriction induced 
physiologically and clinically meaningful changes in metabolism. 
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Appendix A- Actigraphy 
 
 
 
 
1  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 8:26 8:16 8:31 7:22 7:34 7:48 8:07 8:17 4:33 4:14 4:36 4:29 4:34 
 SE% 93.9 91.9 94.6 81.9 84.1 86.7 90.2 92 91 84.7 92 89.7 91.3 
               
2  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 7:37 7:21 7:53 5:59 6:53 7:26 6:01 7:19 3:53 4:14 4:03 4:30 4:13 
 SE% 84.6 81.7 87.6 66.5 76.5 82.6 66.9 81.3 77.7 84.7 81 90 85.2 
               
3  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 8:06 8:02 8:07 7:17 7:29 7:47 7:42 7:25 4:23 4:31 4:08 4:15 4:27 
 SE% 90 89.3 90.2 80.9 83.1 86.5 85.6 82.4 87.7 90.3 82.7 85 89 
               
4  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 7:52 7:07 8:10 4:21 4:32 4:35 4:24 4:36 7:46 8:46 7:25 7:54 8:31 
 SE% 87.4 79.1 91.2 87 90.7 91.7 88 92.9 86.3 97.4 82.4 87.8 94.6 
               
5  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 7:41 8:11 6:48 4:10 4:37 4:33 4:13 4:35 8:03 7:28 7:21 8:17 7:44 
 SE% 86 90.9 75.6 83.3 92.3 91 84.3 91.7 89.4 83 81.7 92 85.9 
               
6  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 7:44 7:42 8:11 7:24 7:50 7:36 7:43 7:33 4:19 4:34 4:38 4:42 4:08 
 SE% 85.9 85.6 90.9 82.2 87 84.4 85.7 83.9 86.3 91.3 92.7 94 82.7 
               
7  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 8:10 7:54 6:40 4:22 4:39 4:35 4:36 4:41 MD 7:46 7:43 7:55 7:31 
 SE% 90.7 87.8 74.1 87.3 93 91.7 92 93.7 MD 86.3 85.7 88 83.5 
               
8  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 7:43 7:45 8:01 4:26 4:28 4:24 4:09 4:22 7:25 7:11 7:14 7:10 7:56 
 SE% 85.7 86.1 89.1 88.7 89.3 88 83.6 87.3 82.4 79.8 80.4 79.6 88.1 
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9  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 8:04 8:30 8:39 7:58 8:25 8:24 8:23 8:27 4:46 4:50 4:43 4:43 4:30 
 SE% 89.6 94.4 96.3 88.5 93.5 93.3 93.1 93.9 95.3 96.7 94.3 94.3 90 
               
10  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 7:52 7:27 8:00 4:27 4:33 4:31 4:32 4:51 7:37 7:26 7:49 7:24 7:40 
 SE% 87.4 82.8 88.9 89 91 90.3 90.7 97 84.6 82.6 86.9 82.2 85.2 
               
11  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 8:08 8:31 8:06 4:52 4:34 4:31 4:48 4:43 8:49 8:53 8:12 8:30 7:59 
 SE% 90.4 94.6 90 97.3 91.3 90.3 96 94.3 98 98.7 91.1 94.4 88.7 
               
12  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 7:50 7:29 7:22 7:25 7:32 7:27 8:09 7:58 4:39 4:25 4:33 4:27 4:37 
 SE% 87 83.1 81.9 82.4 83.7 82.8 90.6 88.5 93 88.3 91 89 92.3 
               
13  
DAY 
1 
DAY 
2 
DAY 
3 
DAY 
4 
DAY 
5 
DAY 
6 
DAY 
7 
DAY 
8 
DAY 
9 
DAY 
10 
DAY 
11 
DAY 
12 
DAY 
13 
 TST 8:00 8:01 8:30 7:59 7:54 7:36 7:53 8:21 4:05 4:43 4:38 4:39 4:36 
 SE% 88.9 89.1 94.4 88.7 87.8 84.4 87.6 92.8 81.7 94.3 92.7 93 92 
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Appendix B- Matsuda Index: Differences Between Conditions 
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Differences in insulin sensitivity for individual subjects at 
baseline and following sleep restriction (5h) and adequate sleep 
(9h) opportunities.  Note large individual differences at baseline 
and following 9h sleep.  The variance in insulin sensitivity in 
the 5h sleep condition appears to be reduced when excluding 
the one subject who is an outlier.  
 
 
